Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
25%
Ph phase_2
4
50%
Ph phase_3
1
13%
Ph not_applicable
1
13%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Other(2)

Detailed Status

Completed3
Recruiting3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 24 (50.0%)
Phase 31 (12.5%)
N/A1 (12.5%)

Trials by Status

completed338%
recruiting338%
unknown225%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_2

SGM-101 in Colorectal Brain Metastases.

NCT04755920
recruitingphase_3

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

NCT03659448
recruitingphase_2

SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia

NCT06280690
completedphase_1

Intraoperative Imaging of Pulmonary Nodules by SGM-101

NCT04315467
unknownphase_2

SGM-101 in Colorectal Lung Metastases

NCT04737213
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04755920Phase 2

SGM-101 in Colorectal Brain Metastases.

Recruiting
NCT03659448Phase 3

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Recruiting
NCT06280690Phase 2

SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia

Recruiting
NCT04315467Phase 1

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Completed
NCT04737213Phase 2

SGM-101 in Colorectal Lung Metastases

Unknown
NCT04642924Phase 2

SGM-101 in Locally Advanced and Recurrent Rectal Cancer

Unknown
NCT02784028Not Applicable

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer

Completed
NCT02973672Phase 1

Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8